Cell Therapeutics Inc. Newsletter
-
Lineage Cell Therapeutics, Inc. (LCTX) Shows Vision Gains in Phase 1/2a OpRegen Trial
25 Sep 2025 11:19 GMT
… Now. Lineage Cell Therapeutics, Inc. is one of them. Lineage Cell Therapeutics, Inc. … manufacturing, and regulatory preparations. Lineage Cell Therapeutics, Inc. (LCTX) Shows Vision … 2a OpRegen Trial Financially, Lineage Cell Therapeutics, Inc. (NYSE:LCTX) …
-
Important Notice to Long-Term Shareholders of Alto Neuroscience, Inc. (NYSE: ANRO); Brainstorm Cell Therapeutics Inc. (OTC: BCLI); Flywire Corporation (NASDAQ: FLYW); and Ibotta, Inc. (NYSE: IBTA): Grabar Law Office is Investigating Claims on Your…
22 Sep 2025 14:02 GMT
… you whatsoever. $ANRO #AltoNeuroScience Brainstorm Cell Therapeutics Inc. (OTC: BCLI) – Survives … company. If you purchased Brainstorm Cell Therapeutics Inc. (OTC: BCLI) … fraud class action complaint, Brainstorm Cell Therapeutics Inc. (OTC: BCLI), through …
-
CERo Therapeutics Announces Third Dose for Patient in Phase 1 Clinical Trial of CER-1236 in AML
21 Oct 2025 12:15 GMT
… immunotherapy company developing novel T cell therapeutics that incorporate phagocytic mechanisms, today … of next generation engineered T cell therapeutics for the treatment of cancer …
-
Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Q2 2025 Earnings Call Transcript
15 Aug 2025 13:56 GMT
… projections regarding Brainstorm Cell Therapeutics and its potential … Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Follow Brainstorm Cell Therapeutics Inc. … Follow Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Follow Brainstorm Cell Therapeutics Inc. …
-
BrainStorm Cell Therapeutics Announces Second Quarter 2025 Financial Results and Provides Corporate Update
14 Aug 2025 11:58 GMT
… developer of adult stem cell therapeutics for neurodegenerative diseases, today … progression.
About BrainStorm Cell Therapeutics Inc.
BrainStorm Cell Therapeutics Inc. (OTCQB: BCLI … brainstorm-cell.com
BRAINSTORM CELL THERAPEUTICS INC. AND SUBSIDIARIES
…
-
Lineage Cell Therapeutics, Inc. (AMEX:LCTX) Q2 2025 Earnings Call Transcript
13 Aug 2025 13:38 GMT
… August 12, 2025
Lineage Cell Therapeutics, Inc. misses on earnings …
Follow Lineage Cell Therapeutics Inc. (NYSE:LCTX) Follow Lineage Cell Therapeutics Inc. ( …
Follow Lineage Cell Therapeutics Inc. (NYSE:LCTX) Follow Lineage Cell Therapeutics Inc. (NYSE …
-
Brainstorm Cell Therapeutics Crashes 42% After Voluntary Nasdaq Delisting Announcement
18 Jul 2025 09:45 GMT
BrainStorm Cell Therapeutics Inc. BCLI shares crashed 42. … Kicks In
CEO of BrainStorm Cell Therapeutics, Chaim Lebovits, on the company … Edge Stock Rankings indicate BrainStorm Cell Therapeutics has a positive short-term …
-
BrainStorm Cell Therapeutics Crashes After Hours On Nasdaq Delisting Notice; Retail Sees 'Buy Time'
18 Jul 2025 06:09 GMT
Shares of BrainStorm Cell Therapeutics slipped in after-hours trading …
-
BrainStorm Cell Therapeutics Announces Nasdaq Delisting and Transition to OTCQB
17 Jul 2025 21:04 GMT
… Lebovits, CEO of BrainStorm Cell Therapeutics, stated, "While … progression.
About BrainStorm Cell Therapeutics Inc.
BrainStorm Cell Therapeutics Inc. (NASDAQ: … news-releases/brainstorm-cell-therapeutics-announces-nasdaq-delisting-and …
-
Natural Killer Cell Therapeutics Market
04 Jul 2025 18:11 GMT
… T-cell receptor (TCR) NK cell therapeutics, leveraging proprietary technologies from both … type, the natural killer cell therapeutics market is segmented into allogeneic … Strategy with Our Natural Killer Cell Therapeutics Market Insights –
• Download the …
About
© 1995-2025